540788
vs
B
BSE Sensex 30
540788
Over the past 12 months, ASPIRA has underperformed BSE Sensex 30, delivering a return of -13% compared to the BSE Sensex 30's 2% drop.
Stocks Performance
540788 vs BSE Sensex 30
Performance Gap
540788 vs BSE Sensex 30
Performance By Year
540788 vs BSE Sensex 30
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Aspira Pathlab & Diagnostics Ltd
Glance View
Aspira Pathlab & Diagnostics Ltd. engages in the operation of diagnostic centers and laboratories. The company is headquartered in Mumbai, Maharashtra. The company went IPO on 2017-12-05. The principal activities of the Company consist of pathology investigation services, radiology investigation services and other related healthcare services at diagnostic centers in Mumbai. The firm carries out pathological investigations in various branches, including bio-chemistry, hematology, histopathology, microbiology, immuno-chemistry, immunology, virology, cytology, other pathological and radiological investigations. The firm's tests include COVID-19 tests, health packages and pathology tests. Its COVID-19 tests include Shanti Screening Test, COVID-19 Antibody Test, COVID-19 Surveillance Profile, COVID-19 RT-PCR Test, COVID-19 Detection Profile 1 and others.
